These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35899180)

  • 1. A systematic review and meta-analysis of abnormalities in hematological and biochemical markers among Bangladeshi COVID-19 cases.
    Bhowmik KK; Barek MA; Aziz MA; Islam MS
    Health Sci Rep; 2022 Jul; 5(4):e728. PubMed ID: 35899180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of hematological and inflammatory parameters associated with disease severity in hospitalized patients of COVID-19.
    Sana A; Avneesh M
    J Family Med Prim Care; 2022 Jan; 11(1):260-264. PubMed ID: 35309629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of serum C-reactive protein (CRP) and D-dimer concentration on the severity of COVID-19 cases with or without diabetes: a systematic review and meta-analysis.
    Debi H; Itu ZT; Amin MT; Hussain F; Hossain MS
    Expert Rev Endocrinol Metab; 2022 Jan; 17(1):83-93. PubMed ID: 34781810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The predictive and prognostic role of hematologic and biochemical parameters in the emergency department among coronavirus disease 2019 patients.
    Huang CY; Tsai HW; Liu CY; Liu TH; Huang HL; Chang CC; Chen WC; Sun JT
    Chin J Physiol; 2021; 64(6):306-311. PubMed ID: 34975124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Retrospective Analysis of the Importance of Biochemical and Hematological Parameters for Mortality Prediction in COVID-19 Cases.
    Mallappa S; Khatri A; Bn G; Kulkarni P
    Cureus; 2022 Oct; 14(10):e30129. PubMed ID: 36381891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis.
    Ghahramani S; Tabrizi R; Lankarani KB; Kashani SMA; Rezaei S; Zeidi N; Akbari M; Heydari ST; Akbari H; Nowrouzi-Sohrabi P; Ahmadizar F
    Eur J Med Res; 2020 Aug; 25(1):30. PubMed ID: 32746929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inflammatory markers of multisystem inflammatory syndrome in children (MIS-C) and adolescents associated with COVID-19: A meta-analysis.
    Zhao Y; Yin L; Patel J; Tang L; Huang Y
    J Med Virol; 2021 Jul; 93(7):4358-4369. PubMed ID: 33739452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients.
    Fathalla LA; Kamal LM; Salaheldin O; Khalil MA; Kamel MM; Fahim HH; Abdel-Moneim YA; Abdulhakim JA; Abdel-Moneim AS; El-Meligui YM
    Int J Immunopathol Pharmacol; 2022; 36():3946320221096207. PubMed ID: 35622504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of hematological, coagulation and biochemical markers in COVID-19 disease and their association with clinical severity and mortality: an Indian outlook.
    Pujani M; Raychaudhuri S; Singh M; Kaur H; Agarwal S; Jain M; Chandoke RK; Singh K; Sidam D; Chauhan V
    Am J Blood Res; 2021; 11(6):580-591. PubMed ID: 35103112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality in Patients of COVID-19 Infection: Biochemical Markers and its Cut-off Values for Predicting Outcome.
    Yousaf MN; Sarwar S; Tarique S; Ahmed M; Tahir H
    J Coll Physicians Surg Pak; 2022 Jan; 32(1):37-41. PubMed ID: 34983145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associated Biochemical and Hematological Markers in COVID-19 Severity Prediction.
    Lamichhane A; Pokhrel S; Thapa TB; Shrestha O; Kadel A; Joshi G; Khanal S
    Adv Med; 2023; 2023():6216528. PubMed ID: 37900669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Profile and Determinants of Mortality in Patients With COVID-19: A Retrospective Analytical Cross-Sectional Study in a Tertiary Care Center in South India.
    Kurien SS; David RS; Chellappan AK; Varma RP; Pillai PR; Yadev I
    Cureus; 2022 Mar; 14(3):e23103. PubMed ID: 35464560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of biomarkers in prognostication of moderate and severe COVID-19 cases.
    Pal S; Sengupta S; Lahiri S; Ghosh A; Bhowmick K
    J Family Med Prim Care; 2023 Dec; 12(12):3186-3193. PubMed ID: 38361890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil to lymphocytic ratio and other inflammatory markers as adverse outcome predictor in hospitalized COVID-19 patients.
    Abdelhady SA; Rageh F; Ahmed SS; Al-Touny SA; Riad E; Elhoseeny MM; Khalifa AA; Salim A; Farghly MI; Elgamal R
    Egypt J Immunol; 2022 Apr; 29(2):57-67. PubMed ID: 35436055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can Hematological Ratios Predict Outcome of COVID-19 Patients? A Multicentric Study.
    Aly MM; Meshref TS; Abdelhameid MA; Ahmed SA; Shaltout AS; Abdel-Moniem AE; Hamad DA
    J Blood Med; 2021; 12():505-515. PubMed ID: 34234607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory Tests and Outcome for Patients with Coronavirus Disease 2019: A Systematic Review and Meta-Analysis.
    Alnor A; Sandberg MB; Gils C; Vinholt PJ
    J Appl Lab Med; 2020 Sep; 5(5):1038-1049. PubMed ID: 32573713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of hematological parameters in the stratification of COVID-19 disease severity.
    Taj S; Kashif A; Arzinda Fatima S; Imran S; Lone A; Ahmed Q
    Ann Med Surg (Lond); 2021 Feb; 62():68-72. PubMed ID: 33437468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematological Profile in COVID-19 Infection Among Patients in a Tertiary Care Hospital in Tamil Nadu, South India.
    Chandran N; Sigamani K; Khadeja Bi A
    Cureus; 2022 Oct; 14(10):e30731. PubMed ID: 36457636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory and hematologic markers as predictors of severe outcomes in COVID-19 infection: A systematic review and meta-analysis.
    Hariyanto TI; Japar KV; Kwenandar F; Damay V; Siregar JI; Lugito NPH; Tjiang MM; Kurniawan A
    Am J Emerg Med; 2021 Mar; 41():110-119. PubMed ID: 33418211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.